> The agency’s commitment is not expected to exceed $150 million to develop novel technologies that will allow surgeons to remove cancerous tumors with higher accuracy. If successful, these technologies will revolutionize surgeries, dramatically reducing rates of repeat procedures.
How does an incremental improvement in surgery (or chemo, or radiotherapy) constitute a cancer "moonshot" in 2024?